Annual Operating Profit
-$35.25 M
+$1.52 M+4.13%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual operaing income is currently -$35.25 million, with the most recent change of +$1.52 million (+4.13%) on 31 December 2022. During the last 3 years, it has risen by +$16.81 million (+32.29%).ZYNE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$11.14 M
-$665.00 K-6.35%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly operating income is currently -$11.14 million, with the most recent change of -$665.00 thousand (-6.35%) on 30 June 2023.ZYNE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$38.79 M
-$1.97 M-5.34%
30 June 2023
Summary:
Zynerba Pharmaceuticals TTM operating income is currently -$38.79 million, with the most recent change of -$1.97 million (-5.34%) on 30 June 2023.ZYNE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +32.3% | -9.1% | -1.7% |
| 5 y5 years | +12.7% | -478.1% | -25.3% |
ZYNE Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +5456.7% | +4557.5% | >+9999.0% |
Zynerba Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$11.14 M(+6.4%) | -$38.79 M(+5.3%) |
| Mar 2023 | - | -$10.47 M(+20.6%) | -$36.82 M(+4.4%) |
| Dec 2022 | -$35.25 M(-4.1%) | -$8.69 M(+2.3%) | -$35.25 M(-0.4%) |
| Sept 2022 | - | -$8.49 M(-7.4%) | -$35.40 M(-4.6%) |
| June 2022 | - | -$9.17 M(+3.0%) | -$37.12 M(-1.8%) |
| Mar 2022 | - | -$8.90 M(+0.8%) | -$37.79 M(+2.8%) |
| Dec 2021 | -$36.77 M(-29.4%) | -$8.84 M(-13.5%) | -$36.77 M(-3.5%) |
| Sept 2021 | - | -$10.21 M(+3.8%) | -$38.12 M(+2.6%) |
| June 2021 | - | -$9.84 M(+24.8%) | -$37.14 M(-24.4%) |
| Mar 2021 | - | -$7.88 M(-22.6%) | -$49.15 M(-5.6%) |
| Dec 2020 | -$52.06 M(+51.7%) | -$10.19 M(+10.4%) | -$52.06 M(-2.3%) |
| Sept 2020 | - | -$9.23 M(-57.7%) | -$53.29 M(+15.9%) |
| June 2020 | - | -$21.84 M(+102.3%) | -$45.98 M(+29.0%) |
| Mar 2020 | - | -$10.80 M(-5.4%) | -$35.65 M(+3.9%) |
| Dec 2019 | -$34.32 M(-15.0%) | -$11.42 M(+492.7%) | -$34.32 M(+10.9%) |
| Sept 2019 | - | -$1.93 M(-83.3%) | -$30.95 M(-16.4%) |
| June 2019 | - | -$11.51 M(+21.6%) | -$37.01 M(-1.2%) |
| Mar 2019 | - | -$9.47 M(+17.7%) | -$37.47 M(-7.3%) |
| Dec 2018 | -$40.40 M | -$8.05 M(+0.8%) | -$40.40 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$7.99 M(-33.3%) | -$40.56 M(-1.4%) |
| June 2018 | - | -$11.97 M(-3.4%) | -$41.12 M(+9.6%) |
| Mar 2018 | - | -$12.40 M(+51.1%) | -$37.52 M(+14.3%) |
| Dec 2017 | -$32.82 M(+41.4%) | -$8.20 M(-4.0%) | -$32.82 M(+4.9%) |
| Sept 2017 | - | -$8.55 M(+2.2%) | -$31.30 M(+8.9%) |
| June 2017 | - | -$8.37 M(+8.6%) | -$28.75 M(+7.8%) |
| Mar 2017 | - | -$7.70 M(+15.2%) | -$26.67 M(+14.9%) |
| Dec 2016 | -$23.21 M(+85.2%) | -$6.68 M(+11.5%) | -$23.21 M(+5.8%) |
| Sept 2016 | - | -$6.00 M(-4.6%) | -$21.94 M(+10.0%) |
| June 2016 | - | -$6.28 M(+48.1%) | -$19.94 M(+30.5%) |
| Mar 2016 | - | -$4.24 M(-21.7%) | -$15.28 M(+21.9%) |
| Dec 2015 | -$12.53 M(+121.1%) | -$5.42 M(+35.6%) | -$12.53 M(+47.1%) |
| Sept 2015 | - | -$4.00 M(+145.5%) | -$8.52 M(+21.0%) |
| June 2015 | - | -$1.63 M(+9.0%) | -$7.04 M(+1.7%) |
| Mar 2015 | - | -$1.49 M(+6.3%) | -$6.92 M(+22.1%) |
| Dec 2014 | -$5.67 M(+793.4%) | -$1.40 M(-44.2%) | -$5.67 M(+32.9%) |
| Sept 2014 | - | -$2.51 M(+66.6%) | -$4.26 M(+143.8%) |
| June 2014 | - | -$1.51 M(+531.3%) | -$1.75 M(+631.3%) |
| Mar 2014 | - | -$239.10 K | -$239.10 K |
| Dec 2013 | -$634.40 K | - | - |
FAQ
- What is Zynerba Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual operaing income?
The current annual operating profit of ZYNE is -$35.25 M
What is the all time high annual operating profit for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual operaing income is -$634.40 K
What is Zynerba Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ZYNE is -$11.14 M
What is the all time high quarterly operating profit for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly operating income is -$239.10 K
What is Zynerba Pharmaceuticals TTM operating income?
The current TTM operating profit of ZYNE is -$38.79 M
What is the all time high TTM operating profit for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high TTM operating income is -$239.10 K